Feasibility Study of the FARAFLEX Mapping and PFA System | MicrobiomeTrials← Back to trialsNCT06510556
Feasibility Study of the FARAFLEX Mapping and PFA System
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2025-02-17Est. Completion: 2027-02-15
Enrollment target: 250 participants Locations- UZ Brussel Hospital, Brussels, Belgium
- Klinicki bolnicki centar Split, Split, Croatia
- Nemocnice Na Homolce Hospital, Prague, Czechia
- Fondazione PTV - Policlinico Tor Vergata, Roma, Italy
Other microbiome trials you might be interested in
Paroxysmal Atrial Fibrillation (PAF)Persistent Atrial Fibrillation
The goal of this clinical trial is to learn if the FARAFLEX™ Mapping and pulsed field ablation (PFA) System can safely a…
Jonesboro, United StatesEst. completion Jul 20, 2028
Diffuse Large B-cell Lymphoma (DLBCL)CardiotoxicityLymphoma
This trial is to evaluate if dexrazoxane is safer and more effective than liposomal doxorubicin in preventing heart fail…
Boston, United StatesEst. completion Dec 31, 2030
Atrial Fibrillation (AF)Atrial Fibrillation Catheter Ablation
The goal of this clinical trial is to test if a more complete ablation procedure works better than the standard procedur…
Beijing, ChinaEst. completion Dec 31, 2028